CAJ | 학술논문

目的观察病炎清Ⅰ号对流感A、B病毒感染患者的疗效.方法对可疑的流感A、B病毒感染者采用酶联免疫吸附试验(ELISA)进行抗原检测,筛选阳性患者108例随机分为A组、B组及C组,A组给予病炎清Ⅰ号颗粒;B组给予病炎清Ⅰ号颗粒+病毒唑片;C组给予病毒唑片,比较三组患者疗效.结果 A组和B组总有效率高于C组,差异具有统计学意义;B组总有效率虽高于A组,但差异没有统计学意义.结论病炎清Ⅰ号治疗流感病毒A、B型感染疗效满意.
목적 관찰병염청Ⅰ호대류감A、B병독감염환자적료효.방법 대가의적류감A、B병독감염자채용매련면역흡부시험(ELISA)진행항원검측,사선양성환자108례수궤분위A조、B조급C조,A조급여병염청Ⅰ호과립;B조급여병염청Ⅰ호과립+병독서편;C조급여병독서편,비교삼조환자료효.결과 A조화B조총유효솔고우C조,차이구유통계학의의;B조총유효솔수고우A조,단차이몰유통계학의의.결론 병염청Ⅰ호치료류감병독A、B형감염료효만의.
Objective To observe the clinic efficacy of Bingyanqing Ⅰ Particles treating the respiratory infections because of influenza A, B virus. Methods Used ELISA Screening cases who are infected by" flu-A, B virus will meet the standard, select 108 cases, randomly assigned to three groups, A, B and C. Give Bingyanqing Ⅰ Particles to the patients of group A, Bingyanqing I Particles and Rirazole to group B, Rirazole to group C. Observe and compare the total efficiency. Results The total efficiency of group A and group B are better than group C, and the difference have statistical significance; although the total efficiency of group B is higher than group A,there has no statistical significance. Don' t find toxic side effects in clinical observation. Conclusion there have satisfactory results that Bingyanqing I Particles treat the infection of influenza A, B virus.